Frontotemporal dementias: Update on recent developments in molecular genetics and neuropathology

Arhiv za Higijenu Rada i Toksikologiju

Volumn 60, Issue 1, 2009, Pages 117-122

  Liščić, Rajka M ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Frontotemporal lobar degeneration; Granulin; Motor neuron disease; Mutation; TARDBP; TDP 43 protein

Indexed keywords

PROGRANULIN; TAR DNA BINDING PROTEIN; VALOSIN CONTAINING PROTEIN;

ALZHEIMER DISEASE; AMNESIA; CHROMOSOME 3; CHROMOSOME 9P; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MOLECULAR GENETICS; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEUROPATHOLOGY; REVIEW;

DEMENTIA; HUMANS;

EID: 63849101317     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-60-2009-1921     Document Type: Review

References (30)

1. Neary D, Snowden JS, Mann DM. Classification and description of frontotemporal dementias. Ann NY Acad Sci 2000;920:46-51.
2. Liscic RM, Storandt M, Cairns NJ, Morris JC. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. Arch Neurol 2007;64:535-40.
3. Liscic R. How to differentiate frontotemporal from Alzheimer's dementia? Recent developments in molecular genetics and neuropathology. Zdrav Vestn 2008;77:71-4.
4. Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 2005;128:597-605.
5. Lipton AM, White CL III, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in76 cases of frontotemporal dementia. Acta Neuropathol 2004;108:379-85.
6. Burratti E, Dork T, Zuccato E, Pagani F, Romano M, Baalle FE. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001;20:1774-84.
7. Burratti E, Brindisi A, Paganini F, Baralle FE. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 2004;74:1322-5.
8. Mercado PA, Ayala YM, Romano M, Burrati E, Baralle FE. Depletion of TDP-43 pverrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 2005;33:6000-10.
9. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. TDP-43 is a component of ubiquitin-positive taunegative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-11.
10. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-3.
11. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D, Snowdon JS, Mann DM. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contains the TAR DNA-binding protein, TDP-43. Acta Neuropathol 2007;113:521-33.
12. Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Paul Taylor J, Kretzschmar HA, Kimonis V, Forman MS. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP mutations. J Neuropathol Exp Neurol 2007;66:152-7.
13. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psych 1994;57:416-8.
14. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: Report of the work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-9.
15. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VMY, Hatanpaa K, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM; Consortium for Frontotemporal Lobar Degeneration. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration: Acta Neuropathol 2007;114:5-22.
16. Ikeda M, Ishikawa T, Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004;17:265-8.
17. Bird T, Knopman D, van Swieten J, Rosso S, Feldman H, Tanabe H, Graff-Raford N, Geschwind D, Verpillat P, Hutton M. Epidemiology and genetics of frontotemporal dementia/ Pick's disease. Ann Neurol 2003;54(Suppl. 5):S29-31.
18. Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 2008;15:772-80.
19. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-9.
20. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442:920-4.
21. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol App Neurobiol 2004;369-73.
22. Rademakers R, Cruts M, van Broeckhoven C. Epidemiology of frontotemporal dementia and related tauopathies. Human Mutation 2004;24:277-95.
23. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosincontaining protein. Nature Genetics 2004;36:377-81.
24. Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608-15.
25. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA. Cognitive profi les differ in autopsy-confi rmed frontotemporal dementia and AD. Neurology 2002;58:1801-8.
26. Behrens MI, Mukherjee O, Tu PH, Liscic RM, Carter D, Taylor-Reinwald L, Norton J, Chakraverty S, Goate A, Morris JC, Cairns. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord 2007;21:1-7.
27. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JSK, Shears S, Behrens MI, Budde J, Hinrichs AL, Norton J, Levitch D, Taylor-Reinwald L, Gitcho M, Tu P-H, Tenenholz Grinberg L, Liscic RM, Armendariz J, Morris JC, Goate AM. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missence mutation in the signal peptide of progranulin. Ann Neurol 2006;60:314-22.
28. Morris JC, Cole M, Banker BQ, Wright D. Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 1984;16:455-66.
29. Lendon CL, Lynch T, Norton J, Goate A. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology 1998;50:1546-55.
30. Spina S, Murrell J, Huey E. Corticobasal syndrome associated with the A9D progranulin mutation. J Neuropathol Exp Neurol 2007;66:892-900.